30Jun
Healthcare M&A prospers, despite fall in deal activity
The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By:
White & Case LLP
Related
The deadline to register with OregonSaves for employers using professional employment organizations ...
Read More >
The Federal Motor Carrier Safety Administration drug and alcohol Clearinghouse opened for registrati...
Read More >
Agreement to Revise Attendance Policy to Accommodate Employees With Disabilities - BALTIMORE - The...
Read More >
On March 31, 2020, Governor Baker issued an order extending his March 23rd emergency order temporari...
Read More >
In a development sure to be welcomed by employers, the U.S. Department of Labor (DOL) issued revised...
Read More >
Let’s face it – your dealership’s employee handbook is likely out of date, even if you just updat...
Read More >